Moreover, although some groups are reported to have greater relative risk of specific breast cancer subtypes, there are no data with which to counsel patients about the absolute magnitude of these risks in comparison with other threats to their health; one clinically important example is the ER-, PR-, and HER2-negative (triple-negative) breast cancer subtype among black women [5]. This evidence concerns the gene ERBB2 and breast carcinoma.